Double-center observational study of minimally invasive sacroiliac joint fusion for sacroiliac joint dysfunction: one-year results.
Journal
Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112
Informations de publication
Date de publication:
28 Dec 2022
28 Dec 2022
Historique:
received:
18
10
2022
accepted:
21
12
2022
entrez:
27
12
2022
pubmed:
28
12
2022
medline:
30
12
2022
Statut:
epublish
Résumé
For a substantial part of patients with chronic low back pain, the origin is located in the sacroiliac joint (SIJ). Minimally invasive sacroiliac joint fusion (MISJF) is increasingly being implemented as a treatment option in SIJ dysfunction. Despite remaining controversy, evidence continues to increase. This study evaluates the clinical results and safety of MISJF in a double-center consecutive case series in patients with SIJ dysfunction over a one-year observation period. SIJ complaints were diagnosed after history taking, physical examination and least a 50% reduction of SIJ pain 30-60 min following image-guided injection. Primary outcome measures were patient reported outcome measurements (PROMs), consisting of Visual Analogue Scale (VAS) pain score and EuroQol 5-dimensions 3-levels (EQ-5D-3L). Patients' perspectives on the effects of surgery were collected through questionnaires. Secondary outcome measures were implant positioning and (serious) adverse events ((S)AE's). A total of 29 patients were included. In 44.8% of patients, SIJ dysfunction was of postpartum origin. The mean VAS-pain score improved from 7.83 (± 1.71) to 4.97 (± 2.63) postoperatively (p < 0.001). EQ-5D-3L score improved from 0.266 (± 0.129) to 0.499 (± 0.260) postoperatively (p < 0.001). Opioid consumption decreased from 44.8 to 24.1% postoperatively (p = 0.026). In 13.7% of patients, an (S)AE occurred. MISJF appears to be an effective and safe procedure in this cohort. Statistically significant and clinically relevant improvements in pain and quality of life were observed one-year postoperatively. Future studies should focus on the long-term outcomes to further evaluate the safety and effectiveness of MISJF.
Sections du résumé
BACKGROUND
BACKGROUND
For a substantial part of patients with chronic low back pain, the origin is located in the sacroiliac joint (SIJ). Minimally invasive sacroiliac joint fusion (MISJF) is increasingly being implemented as a treatment option in SIJ dysfunction. Despite remaining controversy, evidence continues to increase. This study evaluates the clinical results and safety of MISJF in a double-center consecutive case series in patients with SIJ dysfunction over a one-year observation period.
METHODS
METHODS
SIJ complaints were diagnosed after history taking, physical examination and least a 50% reduction of SIJ pain 30-60 min following image-guided injection. Primary outcome measures were patient reported outcome measurements (PROMs), consisting of Visual Analogue Scale (VAS) pain score and EuroQol 5-dimensions 3-levels (EQ-5D-3L). Patients' perspectives on the effects of surgery were collected through questionnaires. Secondary outcome measures were implant positioning and (serious) adverse events ((S)AE's).
RESULTS
RESULTS
A total of 29 patients were included. In 44.8% of patients, SIJ dysfunction was of postpartum origin. The mean VAS-pain score improved from 7.83 (± 1.71) to 4.97 (± 2.63) postoperatively (p < 0.001). EQ-5D-3L score improved from 0.266 (± 0.129) to 0.499 (± 0.260) postoperatively (p < 0.001). Opioid consumption decreased from 44.8 to 24.1% postoperatively (p = 0.026). In 13.7% of patients, an (S)AE occurred.
CONCLUSION
CONCLUSIONS
MISJF appears to be an effective and safe procedure in this cohort. Statistically significant and clinically relevant improvements in pain and quality of life were observed one-year postoperatively. Future studies should focus on the long-term outcomes to further evaluate the safety and effectiveness of MISJF.
Identifiants
pubmed: 36575465
doi: 10.1186/s13018-022-03466-x
pii: 10.1186/s13018-022-03466-x
pmc: PMC9794474
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
570Informations de copyright
© 2022. The Author(s).
Références
Man Ther. 2005 Aug;10(3):207-18
pubmed: 16038856
Arch Orthop Trauma Surg (1978). 1987;106(4):238-40
pubmed: 2956935
Spine J. 2005 Sep-Oct;5(5):520-8; discussion 529
pubmed: 16153580
Asian Spine J. 2017 Feb;11(1):120-126
pubmed: 28243380
Int J Spine Surg. 2020 Feb 10;14(Suppl 1):20-29
pubmed: 32123654
Med Devices (Auckl). 2014 Apr 12;7:73-81
pubmed: 24748825
J Bone Joint Surg Am. 2019 Mar 6;101(5):400-411
pubmed: 30845034
Value Health. 2013 Jan-Feb;16(1):124-32
pubmed: 23337223
Open Orthop J. 2016 Nov 30;10:679-689
pubmed: 28144378
Int J Spine Surg. 2016 Aug 23;10:28
pubmed: 27652199
N Am Spine Soc J. 2021 Sep 29;8:100082
pubmed: 35141647
BMC Med. 2017 Feb 20;15(1):35
pubmed: 28215182
Open Orthop J. 2012;6:495-502
pubmed: 23284593
BMC Musculoskelet Disord. 2014 Mar 15;15:85
pubmed: 24629145
Neurosurgery. 2018 Jan 1;82(1):48-55
pubmed: 28431026
Ann Transl Med. 2020 Mar;8(6):299
pubmed: 32355743
Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):221-33
pubmed: 24625040
Med Devices (Auckl). 2014 Aug 28;7:299-304
pubmed: 25210479
Spine (Phila Pa 1976). 2009 Jan 1;34(1):E27-32
pubmed: 19127145
Fed Pract. 2019 Aug;36(8):370-375
pubmed: 31456628
Chiropr Man Therap. 2016 Feb 15;24:7
pubmed: 26885363
Clin Orthop Relat Res. 1987 Apr;(217):266-80
pubmed: 2951048
J Spine Surg. 2019 Sep;5(3):310-314
pubmed: 31663041
Saudi J Anaesth. 2019 Apr;13(Suppl 1):S31-S34
pubmed: 30930717
Am J Med Genet C Semin Med Genet. 2021 Dec;187(4):429-445
pubmed: 34797601
Global Spine J. 2018 Aug;8(5):453-459
pubmed: 30258750
Med Devices (Auckl). 2018 Apr 09;11:113-121
pubmed: 29674852
Osteoarthritis Cartilage. 2019 Jun;27(6):871-877
pubmed: 30682417
Int J Spine Surg. 2016 Apr 20;10:13
pubmed: 27162715
Neurosurgery. 2015 Nov;77(5):674-90; discussion 690-1
pubmed: 26291338
Ann Surg Innov Res. 2013 Sep 16;7(1):12
pubmed: 24040944
Eur Spine J. 2008 Jun;17(6):794-819
pubmed: 18259783